Suchergebnisse - "Redfern, Andrew"

PubPharm (131)

1

177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p) : an open-label, multicentre, randomised, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Emmett, L. | Subramaniam, S. | Crumbaker, M. | +37

2

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer

enthalten in: BJUI compass | 2024

von Al-Zubaidi, M. | Ong, K. | Viswambaram, P. | +10

3

The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial : first-in-human trial in patients with bladder cancer

enthalten in: BJU international | 2024

von Hayne, D. | Ong, K. | Swarbrick, N. | +12

4

The socioeconomic impact of the COVID-19 lockdown on families affected by childhood respiratory illnesses in Cape Town, South Africa

enthalten in: PLOS global public health | 2024

von Anthony, M. | Hoddinott, G. | Van Niekerk, M. | +6

5

Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence

enthalten in: Cancer medicine | 2024

von Martin, H. | Redfern, A.

6

Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP) : secondary outcomes of a randomised, open-label, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Hofman, M. | Emmett, L. | Sandhu, S. | +60

7

Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence

enthalten in: Cancer Medicine | 2024

von Martin, H. | Redfern, A.

8

Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer

enthalten in: Prostate cancer and prostatic diseases | 2023

von Taaffe, D. | Galvão, D. | Clay, T. | +7

CommentIn: Nat Rev Urol. 2023 Feb;20(2):63. - PMID 36481920

9

Short-term outcomes of South African children with multisystem inflammatory syndrome in children : a prospective cohort study

enthalten in: Archives of disease in childhood | 2023

von Lishman, J. | Abraham, D. | Fourie, B. | +4

10

A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease

enthalten in: European journal of clinical pharmacology | 2023

von Mayer, C. | Koeck, K. | Hottmann, M. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]